Generate a tailored SOP for Dr. Karen Alt. Improve your application with a focused, well-structured draft.
Karen Alt is an immunologist specializing in health sciences research with expertise in antibody engineering and molecular imaging. She is the head of the NanoTheranostics Laboratory at the Australian Centre for Blood Diseases at Monash University. Previously, she was a Senior Research Officer at Monash University and the Facility Manager for the NanoPET/CT Preclinical Imaging Facility at Baker IDI Heart & Diabetes Institute. Dr. Alt is recognized for her contributions to the field of imaging techniques to understand disease progression and the impact of therapies. Her research strategy combines novel enzymatic chemical modification techniques with recombinant antibodies, utilizing bacterial transpeptidase sortase click chemistry for imaging drug delivery. Her work aims to develop new theranostic agents for clinical applications. Dr. Alt’s supervisory interests include understanding fibrosis and the role of matrix metalloproteinases in the progression of various diseases, including organ fibrosis. She has extensively collaborated on research projects focusing on advanced imaging techniques and is deeply involved in peer review processes for several notable journals.
Monash University • Melbourne, Australia
Leading the NanoTheranostics Laboratory and supervising research in molecular imaging and antibody engineering.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.